Maintenance anti-inflammatory therapy
Showing 1 - 25 of >10,000
IBD, Crohn Disease, Ulcerative Colitis Trial in Hartford, Cincinnati, Columbus (2'-Fucosyllactose, Placebo)
Recruiting
- Inflammatory Bowel Diseases
- +2 more
- 2'-Fucosyllactose
- Placebo
-
Hartford, Connecticut
- +2 more
Jan 31, 2022
Reflux Esophagitis, Gastric Ulcer, Duodenal Ulcer Trial in Japan (D961H capsule 10mg, D961H sachet 10mg)
Active, not recruiting
- Reflux Esophagitis
- +2 more
- D961H capsule 10mg
- D961H sachet 10mg
-
Bunkyo-ku, Japan
- +16 more
Jan 3, 2023
Relapsing Multiple Sclerosis Trial in Fort Collins, Farmington (Ublituximab)
Recruiting
- Relapsing Multiple Sclerosis
- Ublituximab
-
Fort Collins, Colorado
- +1 more
May 26, 2023
Acute Decompensated Heart Failure, Cytokine Storm, Inflammatory Response Trial in Jerusalem (Copaxone, guideline directed
Completed
- Acute Decompensated Heart Failure
- +3 more
- Copaxone
- guideline directed medical therapy (GDMT)
-
Jerusalem, IsraelHadassah Ein Kerem medical center-hospital ,Cardiology Departmen
Aug 15, 2023
HER2-positive Metastatic Breast Cancer, Stage IV Breast Cancer Trial in Miami (Discontinuation of Anti-HER-2 Maintenance
Recruiting
- HER2-positive Metastatic Breast Cancer
- Stage IV Breast Cancer
- Discontinuation of Anti-HER-2 Maintenance Treatment
-
Miami, FloridaUniversity of Miami
Jul 17, 2023
Hiv Trial in Nice (plasma inflammatory markers, CD4/CD8 ratio)
Not yet recruiting
- Hiv
- plasma inflammatory markers
- CD4/CD8 ratio
-
Nice, FranceCHU Nice
Jan 16, 2023
Pemphigus, Dermatologic Disease Trial (RiTUXimab Injection)
Not yet recruiting
- Pemphigus
- Dermatologic Disease
- RiTUXimab Injection
- (no location specified)
Jun 7, 2023
Asthma, Severe Eosinophilic Asthma Trial in Worldwide (Symbicort®, Fasenra®, Ventolin®)
Active, not recruiting
- Asthma
- Severe Eosinophilic Asthma
- Symbicort®
- +2 more
-
Brest Cedex, France
- +22 more
Aug 24, 2022
IBD Trial in Leiden (Ferrous fumarate, MonoFer)
Recruiting
- Inflammatory Bowel Diseases
- Ferrous fumarate
- MonoFer
-
Leiden, Zuid-Holland, NetherlandsLeiden University Medical Centre
Oct 12, 2022
Extensive-Stage Small Cell Lung Cancer Trial in Beijing (Surufatinib, Anti-PD-1/L1)
Not yet recruiting
- Extensive-Stage Small Cell Lung Cancer
-
Beijing, ChinaChinese PLA General Hospital
Aug 18, 2022
Schizophrenia Trial in Baltimore (Anti-inflammatory Combination Therapy, Placebo)
Completed
- Schizophrenia
- Anti-inflammatory Combination Therapy
- Placebo
-
Baltimore, MarylandMaryland Psychiatric Research Center
Mar 1, 2022
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Trial in Rozzano (Rituximab)
Active, not recruiting
- Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
-
Rozzano, Milano, ItalyIstituto Clinico Humanitas
May 17, 2023
In-stent Restenosis Trial in Beijing (Colchicine, Prednisone, Aspirin)
Not yet recruiting
- In-stent Restenosis
- Colchicine
- +4 more
-
Beijing, Beijing, ChinaFuwai Hospital
Oct 15, 2023
Pancreatitis, Chronic; Diabetes; Transplant Trial in Minneapolis (etanercept, Alpha 1-Antitrypsin)
Active, not recruiting
- Pancreatitis, Chronic; Diabetes; Transplant
- etanercept
- Alpha 1-Antitrypsin
-
Minneapolis, MinnesotaUniversity of Minnesota
Aug 12, 2022
ANCA-associated Vasculitis, Maintenance Therapy Trial in Beijing (Azathioprine, Telitacicept)
Recruiting
- ANCA-associated Vasculitis
- Maintenance Therapy
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jul 20, 2023
Spondyloarthritis, Crohn Disease, Ulcerative Colitis Trial in Pessac (blood sample, stool samples, food questionnaire)
Completed
- Spondyloarthritis
- +2 more
- blood sample
- +4 more
-
Pessac, FranceCHU de Bordeaux - service d'Hépato-gastroentérologie
May 25, 2022
Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Breast Inflammatory Carcinoma Trial in
Active, not recruiting
- Anatomic Stage IIIB Breast Cancer AJCC v8
- +4 more
- Pembrolizumab
-
Houston, TexasM D Anderson Cancer Center
Sep 30, 2022
Molar, Third, Third Molar Surgery, Soft Tissue Swelling Trial in Lisbon (Combination of corticosteroid (methylprednisolone -
Recruiting
- Molar, Third
- +4 more
- Combination of corticosteroid (methylprednisolone - Medrol, 16mg Pfizer Laboratories) therapy and non-steroidal anti-inflammatory (Ibuprofen 600mg Mylan) therapy
- Non-steroidal anti-inflammatory therapy (Ibuprofen 600mg Mylan)
-
Lisbon, PortugalImplantology Institute
Jul 9, 2023
Systemic Sclerosis Trial in Ankara (Cognitive Exercise Therapy Approach (BETY))
Active, not recruiting
- Systemic Sclerosis
- Cognitive Exercise Therapy Approach (BETY)
-
Ankara, TurkeyHacettepe University
Jul 12, 2022
IBD, Crohn Disease, Colitis, Ulcerative Trial in Belgium, Netherlands, Spain (Infliximab, Adalimumab)
Recruiting
- Inflammatory Bowel Diseases
- +2 more
- Infliximab
- Adalimumab
-
Gent, Belgium
- +6 more
May 17, 2022
AL Amyloidosis Trial in Scottsdale, Jacksonville, Rochester (procedure, biological, other)
Not yet recruiting
- AL Amyloidosis
- Bone Marrow Biopsy
- +4 more
-
Scottsdale, Arizona
- +2 more
Jun 2, 2023
Adverse Effects in the Therapeutic Use of Analgesic, Antipyretic and Anti-Inflammatory Drug, Unspecified Trial (Cocktail
Not yet recruiting
- Adverse Effects in the Therapeutic Use of Analgesic, Antipyretic and Anti-Inflammatory Drug, Unspecified
- Cocktail injection
- (no location specified)
Nov 5, 2023
IBD, Crohn Disease Trial in Los Angeles (Anti-inflammatory diet, Regular diet)
Recruiting
- Inflammatory Bowel Diseases
- Crohn Disease
- Anti-inflammatory diet
- Regular diet
-
Los Angeles, CaliforniaUCLA Center for Human Nutrition, 1000 Veteran Ave.
Nov 9, 2021
Treatment Resistant Depression, MDD, Analgesia Trial in Brooklyn (VTS-K)
Recruiting
- Treatment Resistant Depression
- +12 more
-
Brooklyn, New YorkMaimonides Medical Center
Dec 12, 2022